NO20064783L - Opplosningstabeletter med licarbazepin - Google Patents

Opplosningstabeletter med licarbazepin

Info

Publication number
NO20064783L
NO20064783L NO20064783A NO20064783A NO20064783L NO 20064783 L NO20064783 L NO 20064783L NO 20064783 A NO20064783 A NO 20064783A NO 20064783 A NO20064783 A NO 20064783A NO 20064783 L NO20064783 L NO 20064783L
Authority
NO
Norway
Prior art keywords
licarbazepine
solution tablets
tablets
solution
dibenz
Prior art date
Application number
NO20064783A
Other languages
English (en)
Norwegian (no)
Inventor
Oskar Kalb
Marie-Christine Wolf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0406381A external-priority patent/GB0406381D0/en
Priority claimed from GB0406737A external-priority patent/GB0406737D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20064783L publication Critical patent/NO20064783L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20064783A 2004-03-22 2006-10-23 Opplosningstabeletter med licarbazepin NO20064783L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0406381A GB0406381D0 (en) 2004-03-22 2004-03-22 Organic compounds
GB0406737A GB0406737D0 (en) 2004-03-25 2004-03-25 Organic compounds
PCT/EP2005/002987 WO2005092290A1 (fr) 2004-03-22 2005-03-21 Comprimes solubles contenant licarbazepine

Publications (1)

Publication Number Publication Date
NO20064783L true NO20064783L (no) 2006-12-15

Family

ID=34962439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064783A NO20064783L (no) 2004-03-22 2006-10-23 Opplosningstabeletter med licarbazepin

Country Status (16)

Country Link
US (1) US20070190143A1 (fr)
EP (1) EP1729737A1 (fr)
JP (1) JP2007529563A (fr)
AR (1) AR048672A1 (fr)
AU (1) AU2005226909B2 (fr)
BR (1) BRPI0509014A (fr)
CA (1) CA2558307A1 (fr)
EC (1) ECSP066872A (fr)
IL (1) IL177830A0 (fr)
MA (1) MA28526B1 (fr)
MX (1) MXPA06010809A (fr)
NO (1) NO20064783L (fr)
PE (1) PE20060124A1 (fr)
RU (1) RU2006137329A (fr)
TW (1) TW200534859A (fr)
WO (1) WO2005092290A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
EP2380575B1 (fr) * 2005-05-06 2015-02-25 Bial-Portela & CA, S.A. Acétate d'eslicarbazépine et utilisation
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) * 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
UA115420C2 (uk) * 2010-12-31 2017-11-10 Біал-Портела Енд Ка., С.А. Тверда фармацевтична композиція у формі гранул, що містить езлікарбазепіну ацетат
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
AU2003240654A1 (en) * 2002-05-31 2003-12-19 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
US20050214388A1 (en) * 2004-02-18 2005-09-29 Gorham Thomas R Multivitamin formulations containing controlled-release magnesium
AR048318A1 (es) * 2004-03-22 2006-04-19 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina

Also Published As

Publication number Publication date
AU2005226909B2 (en) 2009-05-14
AU2005226909A1 (en) 2005-10-06
MA28526B1 (fr) 2007-04-03
CA2558307A1 (fr) 2005-10-06
TW200534859A (en) 2005-11-01
AR048672A1 (es) 2006-05-17
JP2007529563A (ja) 2007-10-25
PE20060124A1 (es) 2006-03-07
MXPA06010809A (es) 2006-12-15
ECSP066872A (es) 2006-11-24
EP1729737A1 (fr) 2006-12-13
US20070190143A1 (en) 2007-08-16
WO2005092290A1 (fr) 2005-10-06
IL177830A0 (en) 2006-12-31
BRPI0509014A (pt) 2007-08-07
RU2006137329A (ru) 2008-06-20

Similar Documents

Publication Publication Date Title
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
NO20052739D0 (no) CCR5-antagonister som medikamenter
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
DK1863812T3 (da) Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
NO20081160L (no) Benzimidazoltiofen forbindelser
WO2005067893A3 (fr) Compositions pharmaceutiques contenant du midazolam dans une concentration elevee
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
IL178689A0 (en) Pharmaceutical solution formulations containing 17-aag
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0620229A8 (pt) formulação
NO20064808L (no) Orale matrixformuleringer med licarbazepin
NO20064783L (no) Opplosningstabeletter med licarbazepin
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
ATE508737T1 (de) Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung
WO2007007182A3 (fr) Formes galeniques solides d'agent antiepileptique
UA87152C2 (ru) Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
NO20085285L (no) 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
WO2009054483A1 (fr) Medicament contenant de la salusine-β
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
MY137747A (en) Nasal pharmaceutical piribedil composition
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application